Miso Clinic · Clinical column

Re2O in Daegu: five things worth checking before you book

If you searched for the best clinic for Re2O in Daegu, a set of criteria will serve you better than a name. No public data compares injector skill. But Re2O differs from other boosters in a few concrete ways, and how a clinic explains those differences is something anyone can compare.

Clinical column 9 min September 2026 Miso Clinic Daegu · Dr Lee Chi-Hak

The short version

Re2O is an injectable made from human acellular dermal matrix (hADM) — donated human skin with the cells removed, leaving the collagen scaffold. Unlike other boosters it is not a synthesised material — it is human tissue, which means the chain of custody runs from donation through processing, testing, storage and distribution.

1. Do they tell you where the material comes from?

The first thing in a Re2O consultation should be the origin, not the product name. The material is processed from donated human skin.

The number itself is not the point. Being able to decide after hearing the explanation is. If origin does not come up early, it is a fair question to ask directly.

2. Do they say which layer, and into how many points?

hADM goes into the dermis. But dermal thickness differs across the face — in a study measuring 30 fixed cadavers with a 3D scanner, facial skin was 2.1 ± 0.4 mm and superficial fat 5.2 ± 1.9 mm. The standard deviation is 36% of the mean.

So “which layer, and into how many points” decides the result more than “how many cc.” We reduce the volume and increase the number of points in thin areas — around the eyes or on the neck, material that pools in one spot shows as small beads for longer and more plainly.

What to listen for is whether the answer comes back area by area. If it stops at “into the dermis” with nothing about the area, it is worth asking again.

3. Do they say where the session number came from?

“Three sessions, four weeks apart” is close to a stock phrase in booster consultations. The source of that number differs by category: a regulatory document here, an expert consensus there, manufacturer copy elsewhere, and for some categories we could not find a source at all.

For Re2O the basis is clear enough — three injections one month apart appears in the registered trial protocol. But since that trial has not reported, it does not mean three is optimal. What matters more than the number is whether someone can tell you where it came from.

4. Do they look at your skin before naming a product?

There are roughly seven booster categories, and they aim at different things. Rough texture, thinned dermis and lost volume are three separate problems. So when a consultation opens with a product name, the order is reversed.

What to watch for is simple: do they ask about skin thickness and degree of laxity, what you have had recently, and whether anything hard to reverse is already in that area? A consultation that settles the product before asking those three does not follow the order we would use.

What is and is not established for each category is laid out in skin booster types compared and the collagen booster reference. The formulations of Re2O itself, and how we use them, are on the Re2O product reference.

5. Do they tell you the plan if something happens?

Most reactions are mild and settle within days. Still, the useful thing to hear beforehand is the path when something does not settle: when to come back, what is done then, and who to contact.

That conversation matters more for a material like Re2O, where no reversal agent has been confirmed in a trial. Hyaluronic acid has a dissolving enzyme; other categories do not share that position. We cover this in hyaluronidase.

One more thing. “That can happen” and “if that happens we do this, and if it has not settled by this point we do that” are different answers. The difference is audible in a consultation.

How we decide

We do not offer Re2O as a general-purpose firmness treatment. We work through it in this order.

  • Origin first. We explain that the material is human-derived, and if that is uncomfortable we move to another category.
  • Texture, thickness or volume? If lost volume is the main concern, this is the wrong direction.
  • What is already in the area. Overlapping with something hard to reverse calls for caution.
  • The size of the human evidence, stated plainly. Twenty subjects, 175 subjects, results not posted — we do not hide those numbers.
  • Sessions described as convention. The figure comes from a trial protocol, not from a demonstrated advantage.

Which treatment suits you depends on your skin condition, how much change you want, and what you have already had. For that reason the same named treatment does not always lead us to the same conclusion.

Frequently asked

Which clinic is best for Re2O in Daegu?

Public data cannot answer that. No metric compares injector skill, testimonials do not establish efficacy under Korean medical advertising law, and case volume is not the same as skill. Checking the five points in this article will, however, let you compare clinics meaningfully.

What exactly is Re2O made of?

It is human acellular dermal matrix: donated human skin processed to remove cells, leaving the dermal collagen scaffold, prepared in injectable form. Being human-derived rather than synthesised is the main difference from other boosters.

Is it approved as a medical device?

Re2O is neither a drug nor a medical device; it enters through the human tissue pathway. As a result the approved indication field that other products carry does not exist for this category. The verification route is simply different.

How certain is the effect?

The human evidence is still small: one 20-subject split-face facial study, a registered Korean trial whose results have not been posted, and a 175-subject comparison against cross-linked collagen in which the arms were close. That is not the same as saying it does not work; it means it has not been tested at scale.

How many sessions?

The commonly quoted design is three sessions one month apart, taken from the registered trial protocol. Since that trial has not reported, there is no basis for calling three optimal.

Can it be combined with other boosters?

Yes, if the sites or the timing are separated. Layering over an area that already holds something hard to reverse deserves caution, because attributing a later problem to a cause becomes difficult.

If something goes wrong, can it be dissolved?

Not in the way hyaluronic acid can. We were not able to verify a primary study of any reversal agent for this material, which is why hearing the adverse-event plan beforehand matters more here.

Will it fill a hollow cheek?

No. Re2O is not designed to restore volume; it targets the condition of the dermis. If hollowing is the main concern, another direction fits better.

Read next

Who wrote this

Written and reviewed by Lee Chi-Hak, MD, director of Miso Clinic, Daegu. The treatment standards and injection design here are the ones we use in practice.

4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu, Korea (Exit 1, Kyungpook National University Hospital Station)

+82-53-428-2700 · www.clinicmiso.co.kr

Everything in this column is general information and does not replace medical diagnosis or treatment. Effects and side effects vary with individual skin condition, age and underlying illness, and the same result is not guaranteed for everyone. Any decision to proceed should be made in an in-person consultation with a physician.

← Clinical columns · Reference library · Miso Clinic Daegu

한국어 · English